Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

NCT06905054 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06905054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06905054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
April 15, 2025
Completion date
July 1, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary strictures, liver transplant, complications, primary sclerosing cholangitis, psc